James Waldron, PA
Physician Assistant · Austell, GANPI 1215054853
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 314 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 13.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,240, 3.5 times the $637 reported in 2021. Among physician assistant clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 314 payments — averaging $21.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$913
- AstraZeneca$793
- Sanofi$689
- Jazz Pharmaceuticals Inc.$669
- Grifols USA, LLC$541
- Boehringer Ingelheim$339
- plus $3K from 30 others
What the payments were for
- Food & beverage$6,72698%
- Education$1362%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 60 | $913 |
| AstraZeneca | 40 | $793 |
| Sanofi | 23 | $689 |
| Jazz Pharmaceuticals Inc. | 24 | $669 |
| Grifols USA, LLC | 27 | $541 |
| Boehringer Ingelheim | 16 | $339 |
| Regeneron Healthcare Solutions, Inc. | 12 | $271 |
| Harmony Biosciences LLC | 6 | $245 |
| Baxter Healthcare | 10 | $208 |
| Insmed, Inc. | 7 | $191 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $179 |
| Axsome Therapeutics, Inc. | 8 | $178 |
| Actelion Pharmaceuticals US, Inc. | 8 | $175 |
| Avadel CNS Pharmaceuticals, LLC | 6 | $157 |
| Viatris Specialty LLC | 8 | $141 |
| Mylan Specialty L.p. | 6 | $134 |
| Mallinckrodt Hospital Products Inc. | 5 | $122 |
| Amgen | 6 | $112 |
| Bayer | 5 | $102 |
| Sanofi-aventis U.S. LLC | 1 | $97 |
| Inspire Medical Systems, Inc. | 2 | $78 |
| Resmed Corp | 4 | $65 |
| United Therapeutics Corporation | 3 | $64 |
| Merck | 3 | $55 |
| Pfizer | 3 | $54 |
| Covis Pharma GmbH | 3 | $52 |
| 3b Medical, Inc. | 1 | $49 |
| ANI Pharmaceuticals, Inc. | 2 | $32 |
| Vapotherm Inc | 1 | $27 |
| Noctrix Health, Inc. | 1 | $27 |
| Vifor Pharma, Inc. | 1 | $23 |
| CSL Behring | 1 | $21 |
| Optinose US, Inc. | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
| Olympus America Inc. | 1 | $13 |
How this compares
$6,863 in reported general payments places this provider in the 90th percentile of 3,581 physician assistant providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 52 | $49,086 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 78 | $2,360 |
| Trazodone Hcl | 54 | $630 |
| Azelastine Hcl | 16 | $450 |
| Ipratropium Bromide | 11 | $354 |
| Gabapentin | 36 | $350 |
| Ropinirole Hcl | 21 | $316 |
| Zaleplon | 11 | $225 |
| Zolpidem Tartrate | 42 | $188 |
| Fluticasone Propionate | 25 | $165 |
| Levocetirizine Dihydrochloride | 15 | $151 |
| Eszopiclone | 15 | $118 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 16 | $89 |
| Temazepam | 13 | $88 |
| Montelukast Sodium | 12 | $42 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $913 | $49,08652 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,581 physician assistant providers in Georgia.
Other physician assistant in Austell
- Douglas DiruggieroCartersville$1.3M
- Jennifer CobbsAtlanta$1M
- A BrunnerStockbridge$1M
- Joseph LangshawCalhoun$879K
- Alison MoeAtlanta$410K
- Maggie SchreckAtlanta$389K
- Lisa HillMarietta$190K
- Laura BishopBrunswick$103K
- Jaime AckermanAtlanta$84K
- Richard BurrellBrunswick$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.